IgG Autoantibodies and Arterial Thrombosis in Antiphospholipid Syndrome
Author Information
Author(s): DANIEL LOPEZ, KAUZUKO KOBAYASHI, JOAN T. MERRILL, E. MATSUURA, LUIS R. LOPEZ
Primary Institution: Oklahoma Medical Research Foundation
Hypothesis
The study investigates the association of IgG autoantibodies against b2-glycoprotein I complexed with oxidized LDL with clinical manifestations of antiphospholipid syndrome.
Conclusion
Autoantibodies against b2GPI/oxLDL complexes are significantly associated with arterial thrombosis in patients with antiphospholipid syndrome.
Supporting Evidence
- APS patients had significantly higher levels of IgG anti-b2GPI/oxLig-1 antibodies compared to SLE patients without APS.
- Autoantibodies against b2GPI/oxLDL complexes were only generated in APS patients.
- Antibody levels in APS patients with arterial thrombosis were significantly higher than those with venous thrombosis.
Takeaway
This study found that certain antibodies in the blood of patients with a specific syndrome can help predict if they will have blood clots in their arteries.
Methodology
Serum levels of b2GPI/oxLDL complexes and IgG anti-b2GPI/oxLig-1 autoantibodies were measured in patients with APS, and their association with clinical manifestations was assessed.
Potential Biases
Potential bias in patient selection and reporting of clinical manifestations.
Limitations
The study may not account for all potential confounding factors influencing the results.
Participant Demographics
88 females and 12 males, mean age 44.6 years (range 18-82 years).
Statistical Information
P-Value
0.02
Confidence Interval
null
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website